The US Federal Reserve kept interest rates steady at 4.25%-4.5%, halting rate cuts after a 100 basis point reduction since September. Market expectations for a rate cut have shifted to June. Fed Chair Jerome Powell warned that if inflation remains stubborn or the labor market weakens, rates could stay higher for longer or be further eased. Political factors may influence the decision.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected
January 30, 2025